Evolution of proteomics technologies for understanding respiratory syncytial virus pathogenesis

Expert Rev Proteomics. 2021 May;18(5):379-394. doi: 10.1080/14789450.2021.1931130. Epub 2021 May 31.

Abstract

Introduction: Respiratory syncytial virus (RSV) is a major human pathogen associated with long term morbidity. RSV replication occurs primarily in the epithelium, producing a complex cellular response associated with acute inflammation and long-lived changes in pulmonary function and allergic disease. Proteomics approaches provide important insights into post-transcriptional regulatory processes including alterations in cellular complexes regulating the coordinated innate response and epigenome.Areas covered: Peer-reviewed proteomics studies of host responses to RSV infections and proteomics techniques were analyzed. Methodologies identified include 1)." bottom-up" discovery proteomics, 2). Organellar proteomics by LC-gel fractionation; 3). Dynamic changes in protein interaction networks by LC-MS; and 4). selective reaction monitoring MS. We introduce recent developments in single-cell proteomics, top-down mass spectrometry, and photo-cleavable surfactant chemistries that will have impact on understanding how RSV induces extracellular matrix (ECM) composition and airway remodeling.Expert opinion: RSV replication induces global changes in the cellular proteome, dynamic shifts in nuclear proteins, and remodeling of epigenetic regulatory complexes linked to the innate response. Pathways discovered by proteomics technologies have led to deeper mechanistic understanding of the roles of heat shock proteins, redox response, transcriptional elongation complex remodeling and ECM secretion remodeling in host responses to RSV infections and pathological sequelae.

Keywords: immunoprecipitation-MS; liquid chromatography (LC)-mass spectrometry (MS); respiratory syncytial virus (RSV).

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Chromatography, Liquid
  • Humans
  • Proteome
  • Proteomics
  • Respiratory Syncytial Virus Infections*
  • Respiratory Syncytial Virus, Human*

Substances

  • Proteome